AU Stock MarketDetailed Quotes

Tryptamine Therapeutics Ltd (TYP)

Watchlist
  • 0.034
  • 0.0000.00%
20min DelayTrading Nov 20 15:54 AET
54.72MMarket Cap-8.50P/E (Static)

Tryptamine Therapeutics Ltd (TYP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
520.24%618.57K
99.73K
Operating revenue
----
520.24%618.57K
--99.73K
----
----
----
Cost of revenue
Gross profit
520.24%618.57K
99.73K
Operating expense
6.73M
-28.16%10.21M
12.20%14.21M
58.24%12.67M
237.52%8M
2.37M
Selling and administrative expenses
--4.28M
-32.85%6.5M
17.61%9.68M
71.73%8.23M
251.40%4.79M
--1.36M
-Selling and marketing expense
----
-67.66%93.8K
-12.35%290.07K
139.99%330.96K
--137.91K
----
-General and administrative expense
--4.28M
-31.77%6.41M
18.87%9.39M
69.71%7.9M
241.29%4.65M
--1.36M
Research and development costs
--2.4M
-31.67%1.73M
-19.93%2.54M
20.89%3.17M
427.34%2.62M
--496.69K
Depreciation amortization depletion
--54.34K
-1.56%1.7M
71.75%1.73M
163.16%1.01M
537.29%382.42K
--60.01K
-Depreciation and amortization
--54.34K
-1.56%1.7M
71.75%1.73M
163.16%1.01M
537.29%382.42K
--60.01K
Other operating expenses
----
2.71%276.74K
1.81%269.45K
25.35%264.65K
-53.21%211.14K
--451.28K
Operating profit
-6.73M
32.04%-9.59M
-11.41%-14.11M
-58.24%-12.67M
-237.52%-8M
-2.37M
Net non-operating interest income (expenses)
-1.8K
-300.58%-313.28K
-1,209.46%-78.21K
-88.36%7.05K
110.43%60.58K
28.79K
Non-operating interest income
--5.79K
494.44%17.95K
-57.17%3.02K
-88.36%7.05K
110.43%60.58K
--28.79K
Non-operating interest expense
--7.59K
307.79%331.23K
--81.23K
----
----
----
Other net income (expenses)
1.4M
-32.44%2.77M
-2.03%4.11M
57.26%4.19M
2.67M
Special income (charges)
---139.06K
----
----
----
----
----
-Less:Impairment of capital assets
--139.06K
----
----
----
----
----
Other non-operating income (expenses)
--1.54M
-32.44%2.77M
-2.03%4.11M
57.26%4.19M
--2.67M
----
Income before tax
-5.33M
29.29%-7.13M
-19.08%-10.08M
-60.42%-8.47M
-131.23%-5.28M
-2.28M
Income tax
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
-5.33M
29.29%-7.13M
-19.08%-10.08M
-60.42%-8.47M
-131.23%-5.28M
-2.28M
Net income continuous operations
---5.33M
29.29%-7.13M
-19.08%-10.08M
-60.42%-8.47M
-131.23%-5.28M
---2.28M
Noncontrolling interests
Net income attributable to the company
-5.33M
29.29%-7.13M
-19.08%-10.08M
-60.42%-8.47M
-131.23%-5.28M
-2.28M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-5.33M
29.29%-7.13M
-19.08%-10.08M
-60.42%-8.47M
-131.23%-5.28M
-2.28M
Diluted earnings per share
-0.0039
36.26%-0.0905
0.93%-0.142
-15.30%-0.1433
-39.45%-0.1243
-0.0891
Basic earnings per share
-0.0039
36.26%-0.0905
0.93%-0.142
-15.30%-0.1433
-39.45%-0.1243
-0.0891
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue 520.24%618.57K99.73K
Operating revenue ----520.24%618.57K--99.73K------------
Cost of revenue
Gross profit 520.24%618.57K99.73K
Operating expense 6.73M-28.16%10.21M12.20%14.21M58.24%12.67M237.52%8M2.37M
Selling and administrative expenses --4.28M-32.85%6.5M17.61%9.68M71.73%8.23M251.40%4.79M--1.36M
-Selling and marketing expense -----67.66%93.8K-12.35%290.07K139.99%330.96K--137.91K----
-General and administrative expense --4.28M-31.77%6.41M18.87%9.39M69.71%7.9M241.29%4.65M--1.36M
Research and development costs --2.4M-31.67%1.73M-19.93%2.54M20.89%3.17M427.34%2.62M--496.69K
Depreciation amortization depletion --54.34K-1.56%1.7M71.75%1.73M163.16%1.01M537.29%382.42K--60.01K
-Depreciation and amortization --54.34K-1.56%1.7M71.75%1.73M163.16%1.01M537.29%382.42K--60.01K
Other operating expenses ----2.71%276.74K1.81%269.45K25.35%264.65K-53.21%211.14K--451.28K
Operating profit -6.73M32.04%-9.59M-11.41%-14.11M-58.24%-12.67M-237.52%-8M-2.37M
Net non-operating interest income (expenses) -1.8K-300.58%-313.28K-1,209.46%-78.21K-88.36%7.05K110.43%60.58K28.79K
Non-operating interest income --5.79K494.44%17.95K-57.17%3.02K-88.36%7.05K110.43%60.58K--28.79K
Non-operating interest expense --7.59K307.79%331.23K--81.23K------------
Other net income (expenses) 1.4M-32.44%2.77M-2.03%4.11M57.26%4.19M2.67M
Special income (charges) ---139.06K--------------------
-Less:Impairment of capital assets --139.06K--------------------
Other non-operating income (expenses) --1.54M-32.44%2.77M-2.03%4.11M57.26%4.19M--2.67M----
Income before tax -5.33M29.29%-7.13M-19.08%-10.08M-60.42%-8.47M-131.23%-5.28M-2.28M
Income tax 000000
Earnings from equity interest net of tax
Net income -5.33M29.29%-7.13M-19.08%-10.08M-60.42%-8.47M-131.23%-5.28M-2.28M
Net income continuous operations ---5.33M29.29%-7.13M-19.08%-10.08M-60.42%-8.47M-131.23%-5.28M---2.28M
Noncontrolling interests
Net income attributable to the company -5.33M29.29%-7.13M-19.08%-10.08M-60.42%-8.47M-131.23%-5.28M-2.28M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -5.33M29.29%-7.13M-19.08%-10.08M-60.42%-8.47M-131.23%-5.28M-2.28M
Diluted earnings per share -0.003936.26%-0.09050.93%-0.142-15.30%-0.1433-39.45%-0.1243-0.0891
Basic earnings per share -0.003936.26%-0.09050.93%-0.142-15.30%-0.1433-39.45%-0.1243-0.0891
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More